Favorable Safety Profile and Durable Responses to Pmb-CT01 (BAFFR-CAR T Cell) Therapy in Patients with B-Cell Lymphomas Ineligible for or Who Failed CD19-Targeted Therapy, Including CD19-Negative Disease
Marissa Morales Del Real,John H. Baird,Lu Chen,Joo Y. Song,Xiuli Wang,Swetha Kambhampati,Alan Macias,Emanuela Marcucci,Soung-chul Cha,Zhenyuan Dong,Teresa S. Kim,Baishakhi Barva,Sandrine Puverel,Qing Liu-Michael,Hazel Ting-Ying Cheng,Stephen J. Forman,Larry W. Kwak,Lihua E. Budde
PDF的下载单位、IP信息已删除
(2025-6-4)
Copyright
cdercder
Kao
东方元语
伶俐妙海
OK
Nole
Nexus
无极微光
arniu2008
小小
柏柏
GingerF
Criminology34
zho
柑橘乌云
初景
sagitar
传统的故事
pcr163
皖公网安备34019202002308
